Lawrence J. Hineline - Net Worth and Insider Trading
Lawrence J. Hineline Net Worth
The estimated net worth of Lawrence J. Hineline is at least $0 dollars as of 2024-11-06. Lawrence J. Hineline is the SVP of Finance, CFO of Intra-Cellular Therapies Inc and owns about 0 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $0. Details can be seen in Lawrence J. Hineline's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lawrence J. Hineline has not made any transactions after 2024-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lawrence J. Hineline
Lawrence J. Hineline Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence J. Hineline owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .
Click here to see the complete history of Lawrence J. Hineline’s form 4 insider trades.
Insider Ownership Summary of Lawrence J. Hineline
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ITCI | Intra-Cellular Therapies Inc | 2024-03-11 | VP of Finance & CFO & Secretary |
Lawrence J. Hineline Latest Holdings Summary
Lawrence J. Hineline currently owns a total of 1 stock. Lawrence J. Hineline owns 0 shares of Intra-Cellular Therapies Inc (ITCI) as of March 11, 2024, with a value of $0.
Latest Holdings of Lawrence J. Hineline
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ITCI | Intra-Cellular Therapies Inc | 2024-03-11 | 0 | 89.24 | 0 |
Holding Weightings of Lawrence J. Hineline
Lawrence J. Hineline Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence J. Hineline has made a total of 21 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 23,253 shares on March 11, 2024, which brought Lawrence J. Hineline around $2 Million.
Insider Trading History of Lawrence J. Hineline
- 1
Lawrence J. Hineline Trading Performance
Lawrence J. Hineline Ownership Network
Ownership Network List of Lawrence J. Hineline
Ownership Network Relation of Lawrence J. Hineline
Lawrence J. Hineline Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Lawrence J. Hineline is the VP of Finance & CFO & Secretary of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , EVP & Chief Commercial Officer Mark Neumann , and Chief Medical Officer Suresh K. Durgam .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Lawrence J. Hineline made 4 insider transaction in Intra-Cellular Therapies Inc (ITCI) with a net sale of 129,627. Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 696,112 shares made by Sharon Mates , a net sale of 156,651 shares made by Mark Neumann , and a net sale of 105,827 shares made by Suresh K. Durgam .
In summary, during the past 3 months, insiders sold 305,712 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 305,712 shares. During the past 18 months, 1,299,251 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,299,251 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Lawrence J. Hineline Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence J. Hineline. You might contact Lawrence J. Hineline via mailing address: C/o Intra-cellular Therapies, Inc., 3960 Broadway, New York Ny 10032.